A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)
Public ClinicalTrials.gov record NCT06881251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
95475939ADM2001: 95475939ADM2001 Ph IIB Trial (N=210)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate how well JNJ-95475939 works as compared to placebo in participants with moderate to severe atopic dermatitis.
Study identification
- NCT ID
- NCT06881251
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 256 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 26, 2025 (Actual)
- Primary completion
- Mar 26, 2026 (Actual)
- Completion
- Apr 7, 2026 (Actual)
- Last update posted
- Jul 31, 2026
2025 – 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| University of California Los Angeles - Division of Dermatology | Los Angeles | California | 90024 | — |
| Hamilton Research LLC | Alpharetta | Georgia | 30022 | — |
| DeNova Research | Chicago | Illinois | 60602 | — |
| Dawes Fretzin Clinical Research Group LLC | Indianapolis | Indiana | 46250 | — |
| Indiana Clinical Trial Center | Plainfield | Indiana | 46168 | — |
| Red River Research Partners LLC | Fargo | North Dakota | 58103 | — |
| Optima Research | Boardman | Ohio | 44512 | — |
| Oregon Medical Research Center | Portland | Oregon | 97201 | — |
| Arlington Center for Dermatology | Arlington | Texas | 76011 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| Frontier Derm Partners CRO, LLC | Mill Creek | Washington | 98012 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06881251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2026 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06881251 live on ClinicalTrials.gov.